In Wolf Theiss' series focusing on key markets in the CEE/SEE, we explore Romania, which is ripe for an M&A revival.

The global pandemic, ageing populations and the burgeoning biotech subsector mean that the pharmaceuticals, medical and biotech (PMB) sector is set to see robust M&A activity in 2021.

European non-performing loan trends in a post-COVID-19 world

Pension funds and institutional investors are demanding better ESG reporting and compliance from infrastructure funds as asset performance data grows. An Inframation survey on the topic last month finds out how they are coping. Colin Leopold reports

Infrastructure fund managers have seen investment values plummet in the safest part of their portfolio, while value-add strategies have outperformed. They are also expanding investment teams and staring through a battered global economy, reports Colin Leopold

In Wolf Theiss' series focusing on key markets in the CEE/SEE, we look at the Czech Republic, where dealmaking was relatively stable despite the pandemic.

Despite, the pandemic hitting volume, the biggest deal in the region saw value in industrials and chemicals M&A rise significantly.

• Cross-border activity makes strong return with USD 516.6bn recorded in 1Q21
• US reaches highest global market share in 14 years
• SPACs help IPO activity surge to USD 200.9bn in 1Q21
• PE sponsors deployment amounts to USD 683.5bn since 3Q20

In Wolf Theiss' series focusing on key markets in the CEE/SEE, we turn our attention to Austria, which saw an upturn in its dealmaking fortunes in 2020.

The dealmaking climate in the energy, mining and utilities (EMU) sector in 2020 was distinctly gloomy, and the outlook for the coming year is mixed, according to our survey with Wolf Theiss.

In Wolf Theiss' series focusing on key markets in the CEE/SEE, we turn our attention to Poland, the largest economy in the region.

Lockdowns and a lack of discretionary spending hit M&A hard last year, but vaccines and distressed deals promise a brighter 2021.

Dealmakers pushed deal totals to new heights in H2 2020, setting the stage for a potentially robust year ahead

Survey of 100 global investors shows sentiment is robustly positive even through a year of pandemic and market uncertainties

Our survey conducted with Wolf Theiss reveals that dealmakers are cautiously optimistic about post-pandemic prospects for M&A in the region with new opportunities emerging. But challenges still lie ahead.

Despite the pandemic, an economic downturn and restrictions on both the general public and dealmakers, deal value in 2020 in CEE/SEE increased year on year. And our exclusive survey with Wolf Theiss reveals growing levels of optimism for the year ahead